Indivior Plc(INDV)

Description: Indivior PLC (Indivior) is a specialty pharmaceutical company. The Company is engaged in the development, manufacture and sale of prescription drugs that are based on buprenorphine for treatment of opioid dependence segment. The Company's treatment and pipeline focuses on opioid use disorder, alcohol use disorder, overdose rescue and co-morbidities of addiction/schizophrenia. Indivior's products, which are sold in over 40 countries, consist of Suboxone film (buprenorphine and naloxone), Suboxone tablet (buprenorphine and naloxone) and Subutex tablet (buprenorphine sublingual tablet), all of which are used to treat opioid dependence. Its Buprenorphine lifecycle includes Suboxone Tablet, Suboxone Film, Buprenorphine Monthly Depot and Oral Swallowable Capsule. Its overdose rescue product category includes Cocaine Esterase. Its alcohol use disorders product category includes Arbaclofen Placarbil. Its adjacency-schizophrenia product category includes Risperidone Monthly Depot.

---

Keywords: Pharmaceutical Drugs Pipe Disorders Opioids Morphinans Addiction Drug Rehabilitation Opioid Use Disorder Naloxone Buprenorphine D Pipeline Opioid Antagonists Erase Indivior Alcohol Use Disorders

---

Home Page: www.indivior.com

INDV Technical Analysis

10710 Midlothian Turnpike
North Chesterfield, VA 23235
United States
Phone: 804 379 1090

---

Officers

Exchange: LSE

Country: UK

Currency: Pence sterling (p)